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Key points
 AMP-activated protein kinase (AMPK) is considered a major regulator of skeletal muscle
metabolism during exercise.
 However, we previously showed that, although AMPK activity increases by 8–10-fold during
120 min of exercise at 65% V̇O2peak in untrained individuals, there is no increase in these
individuals after only 10 days of exercise training (longitudinal study).
 In a cross-sectional study, we show that there is also a lack of activation of skeletal muscle
AMPK during 120 min of cycling exercise at 65% V̇O2peak in endurance-trained individuals.
 These findings indicate that AMPK is not an important regulator of exercise metabolism during
120 min of exercise at 65% V̇O2peak in endurance trained men.
 It is important that more energy is directed towards examining other potential regulators of
exercise metabolism.
Abstract AMP-activated protein kinase (AMPK) is considered a major regulator of skeletal
muscle metabolism during exercise. Indeed, AMPK is activated during exercise and activation of
AMPK by 5-aminoimidazole-4-carboxyamide-ribonucleoside (AICAR) increases skeletal muscle
glucose uptake and fat oxidation. However, we have previously shown that, although AMPK
activity increases by 8–10-fold during 120 min of exercise at 65% V̇O2peak in untrained
individuals, there is no increase in these individuals after only 10 days of exercise training
(longitudinal study). In a cross-sectional study, we examined whether there is also a lack of
activation of skeletal muscle AMPK during 120 min of cycling exercise at 65% V̇O2peak in
endurance-trained individuals. Eleven untrained (UT; V̇O2peak = 37.9 ± 5.6 ml.kg−1 min−1)
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and seven endurance trained (ET; V̇O2peak = 61.8 ± 2.2 ml.kg−1 min−1) males completed 120 min
of cycling exercise at 66 ± 4% V̇O2peak (UT: 100 ± 21 W; ET: 190 ± 15 W). Muscle biopsies
were obtained at rest and following 30 and 120 min of exercise. Muscle glycogen was significantly
(P < 0.05) higher before exercise in ET and decreased similarly during exercise in the ET and
UT individuals. Exercise significantly increased calculated skeletal muscle free AMP content and
more so in the UT individuals. Exercise significantly (P < 0.05) increased skeletal muscle AMPK
α2 activity (4-fold), AMPK αThr172 phosphorylation (2-fold) and ACCβ Ser222 phosphorylation
(2-fold) in the UT individuals but not in the ET individuals. These findings indicate that AMPK
is not an important regulator of exercise metabolism during 120 min of exercise at 65% V̇O2peak
in endurance trained men.
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Introduction
The signalling events that regulate skeletal muscle exercise
metabolism have not been fully elucidated (Richter &
Hargreaves, 2013). There is evidence for feed forward
(calcium activated CaMK) (Wright et al. 2004; Wright
et al. 2005; Jensen et al. 2007; Witczak et al. 2010)
and feedback (AMP-activated protein kinase; AMPK)
(Hayashi et al. 1998; Mu et al. 2001; Lee-Young et al.
2009; Abbott et al. 2011) regulation being involved,
as well as nitric oxide (Balon & Nadler, 1997; Roberts
et al. 1997; Bradley et al. 1999; Inyard et al. 2007; Ross
et al. 2007; Merry et al. 2010a) and reactive oxygen
species production (Toyoda et al. 2004; Sandstrom et al.
2006; Merry et al. 2010a), which are increased during
contraction (Roberts et al. 1999; Reid & Durham, 2002;
Linden et al. 2011). There is also some evidence that
cytosketetal forces during contraction may signal glucose
uptake via Rac1 (Sylow et al. 2013; Sylow et al. 2015).
Skeletal muscle AMPK activity increases during exercise
in rodents (Winder & Hardie, 1996; Lee-Young et al.
2009) and humans (Chen et al. 2000; Fujii et al. 2000;
Wojtaszewski et al. 2000; Musi et al. 2001; Mortensen et al.
2013) and, given that activation of AMPK by 5-amino-
imidazole-4-carboxyamide-ribonucleoside (AICAR)
increases skeletal muscle glucose uptake and fat oxidation
(Merrill et al. 1997; Hayashi et al. 2000; Jorgensen et al.
2004), it has been assumed that activation of AMPK
during exercise increase fat and glucose metabolism
in humans. However, a number of studies have shown
dissociations between activation of AMPK and glucose
uptake during muscle contraction in rodents (Jorgensen
et al. 2004; Fujii et al. 2005; Kjobsted et al. 2017) and
during exercise in humans (Wojtaszewski et al. 2000;
McConell et al. 2005; Mortensen et al. 2013). In addition,
several studies have shown that fat oxidation increases
normally during contraction (Jeppesen et al. 2011) and
during exercise (Jeppesen et al. 2013) in AMPK dominant
negative/kinase dead mice.
Further evidence that questions a role for AMPK in
glucose and fat metabolism during exercise is that sub-
stantial increases in glucose uptake and fat oxidation are
seen during low intensity exercise (40–45% V̇O2peak) in
humans even though AMPK signalling is not increased
at such intensities (Wojtaszewski et al. 2002; Chen et al.
2003). In addition, in a longitudinal study, we showed in
previously untrained men that 10 days of exercise training
abolishes the 10-fold increase in AMPK α2 activity
during exercise at 65% V̇O2peak despite fat oxidation being
higher and glucose disposal, although attenuated, still
being substantially increased during exercise (McConell
et al. 2005). We found no relationship between AMPK
activation (and AMPK αThr172 phosphorylation and
ACCβ phosphorylation) and muscle glycogen use, glucose
uptake and fat oxidation during exercise (McConell
et al. 2005). There is no doubt that AMPK activation
during exercise is important for post-exercise adaptations
(Winder et al. 2000; McGee et al. 2003), although these
findings imply that AMPK activation during moderate
intensity exercise is not necessary for normal increases in
glucose uptake and fat oxidation during exercise.
It can be argued that there is less activation of AMPK
after short-term exercise training because there is less of an
energy deficit in skeletal muscle during exercise. Indeed,
we found this to be the case in humans in our short-term
training study reporting no activation of AMPK during
exercise at 65% of pretraining V̇O2peak (McConell et al.
2005). The exercise after training was conducted at the
pre-exercise training workload; as such, the exercise was
at a little lower relative workload after training (McConell
et al. 2005). However, it has subsequently been shown
in humans that, after 12 weeks of exercise training,
there is less activation of skeletal muscle AMPK when
the post training exercise was conducted at the same
relative intensity of 65% V̇O2peak as the pre-training exercise
(Mortensen et al. 2013).
Another way of examining the effect of exercise training
on AMPK activation is to conduct a cross-sectional study
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comparing endurance trained with untrained individuals
exercising at the same relative intensity. Nielsen et al.
(2003) found similar increases in AMPK α2 activity during
20 min of exercise at 80% V̇O2peak in trained compared
with untrained individuals. This was surprising because
they and others have found less of a skeletal muscle
energy imbalance and therefore less of an increase in
skeletal muscle AMP and ADP at 80% V̇O2peak in trained
compared with untrained men (Baldwin et al. 1999;
Nielsen et al. 2003). It is not known whether skeletal
muscle AMPK activity would increase during prolonged
moderate intensity exercise in well trained individuals.
This is important to determine because, if AMPK does not
increase during such exercise, this would imply that AMPK
is not important for the regulation of exercise metabolsim
during such exercise.
Therefore, the present study aimed to examine whether
long-term endurance exercise trained individuals have
an increase in skeletal muscle AMPK during 120 min
of exercise at 65% V̇O2peak. Based on our findings of
no activation at this workload in previously untrained
individuals after 10 days of exercise training (McConell
et al. 2005), we hypothesized that skeletal muscle AMPK
would not be activated during 120 min of exercise at 65%
V̇O2peak in endurance trained men.
Methods
Ethical approval
The present study was approved by the Human Research
Ethics Committee of the University of Melbourne (Study
number 040090) and conducted in accordance with
the Declaration of Helsinki, except for registration in a
database.
Subjects
Seven endurance-trained cyclists and triathletes (26 ± 2
years; 72 ± 4 kg; V̇O2peak = 4.4 ± 0.35 L min−1,
mean ± SD) and eleven healthy but otherwise untrained
(23 ± 3 years; 69 ± 9 kg; V̇O2peak = 2.6 ± 0.4 L min−1,
mean ± SD) non-smoker males participated in the
study (Table 1). Trained participants cycled on average
300 ± 100 km week–1, whereas untrained participants
undertook no regular exercise.
Experimental design
Participants were required to attend the laboratory
on three separate occasions. The first visit involved
a peak pulmonary oxygen consumption test during
cycling (V̇O2peak), followed 2–3 days later by a 30 min
familiarisation ride at a workload calculated from the
Table 1. Subject characteristics
Parameter Untrained Trained
Age (years) 23 ± 3 26 ± 2
Weight (kg) 69 ± 9 72 ± 4
Height (m) 1.75 ± 0.35 1.76 ± 0.39
BMI (kg m–2) 22 ± 2.6 23 ± 0.76
V̇O2peak (L min
−1) 2.60 ± 0.4∗ 4.44 ± 0.35
V̇O2peak
(ml kg−1 min−1)
37.9 ± 5.6∗ 61.8 ± 2.2
Values are the mean ± SD, n = 11 untrained and 7 exercise
trained participants, BMI, body mass index, V̇O2 , oxygen
consumption. ∗Significantly different to corresponding trained
value (P < 0.05).
V̇O2peak test to be 65% V̇O2peak to confirm the power
output for the experimental trials. Approximately 1 week
later, participants returned to the laboratory for an exercise
trial, which involved cycling for 120 min at  65% V̇O2peak
(untrained; 100 ± 21 W; trained 190 ± 15) (Table 2).
Dietary and exercise controls
All participants were asked to refrain from any formal
exercise for 48 h prior to the experimental trial to minimise
any acute exercise training effects and to avoid drinking
alcohol or consumption of caffeine for 24 h prior. To
ensure the energy intake was controlled between groups,
participants were supplied with a diet to consume over the
24 h prior to each experimental trial containing 199
kJ kg–1 consisting of 65% of carbohydrates, 15%
proteins and  20% fats. Participants were instructed
to adhere to the diet but to consume water ad libitum
and to finish the food by 10pm the evening prior to the
experimental trial to enable attending the laboratory in a
fasted state.
Exercise trials
On the morning of the exercise trial, a 22 gauge Teflon
catheter (Optiva; Ethicon Endo-Surgery, Cincinnati, OH,
USA) was inserted into an antecubital forearm vein for
blood sampling. The exercise protocol consisted of cycling
for 120 min at 65% of V̇O2peak. Blood was sampled 10 min
prior to the commencement of exercise and then every
30 min during exercise for the measurement of plasma
glucose, lactate, insulin, glycerol and free fatty acids.
Expired air was collected into Douglas bags every 30 min
during exercise and heart rate (Polar Favor, Oulu, Finland)
was recorded every 30 min during exercise. V̇O2 and
the respiratory exchange ratio were calculated from the
expired air samples. Participants received 8 ml kg−1 body
weight of water at the start of exercise, followed by a further
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Table 2. Physiological responses during 120 min of steady-state
exercise at  65% V̇O2peak
Parameter Untrained Trained
% of V̇O2peak (ml.kg
−1 min−1) 66 ± 4.5 65 ± 1.6
Workload (watts) 100 ± 21∗ 190 ± 15
RER 0.91 ± 0.56 0.91 ± 0.38
RPE 12.4 ± 1.2 11.0 ± 1.5
Heart rate (beats min–1) 147 ± 9 143 ± 7
Data are the mean ± SD, n = 11 untrained and 7 exercise
trained participants. V̇O2 , oxygen consumption, RER, respiratory
exchange ratio, RPE, rating of perceived exhaustion.
∗Significantly different to corresponding trained value (P < 0.05).
2 ml kg−1 body weight every 15 min of exercise and were
fan cooled throughout the trial. At rest and after 30 and
120 min of exercise, muscle was obtained from the vastus
lateralis under local anaesthesia, using the percutaneous
needle biopsy technique, with suction. Muscle samples
were rapidly (8–12 s from stopping exercise) frozen and
stored in liquid N2 for later analysis of AMPK α1 and
α2 activity, AMPK αThr172 phosphorylation and ACCβ
Ser222 phosphorylation and muscle metabolites.
Analytical techniques
Blood. Plasma glucose, lactate (Lowry OH, 1972) and
glycerol (Chernick, 1969) were determined using an
enzymatic fluorometric procedure, plasma non-esterified
fatty acids (NEFA) by an enzymatic colorimetric method
(NEFA-C test, Wako, Osaka, Japan) and plasma insulin
using a human insulin-specific radioimmunoassay kit
(Linco Research, St Charles, MO, USA).
Muscle metabolites. A portion of each muscle sample
(20 mg) was freeze-dried and subsequently crushed
to a powder and any visible connective tissue was
removed. The extraction of muscle glycogen commenced
by incubating the sample in HCl before being neutralized
with NaOH and subsequently analysed for glucosyl units
using an enzymatic flurometric method (Passonneau &
Lauderdale, 1974). The metabolites (ATP, CrP, Cr and
lactate) were extracted firstly with precooled perchloric
acid/EDTA before the addition of precooled KHCO3 to the
supernatant. The metabolites were analysed in triplicate
using an enzymatic flurometric method as reported by
Harris et al. (1974). PCr, Cr and ATP were normalised to
the participant’s highest total creatine (Cr + CrP). The
concentration of ADP (ADPfree) and AMP (AMPfree) was
calculated based on the near equilibrium nature of the CK
and adenylate kinase reactions, respectively. ADPfree was
calculated from the measured ATP, Cr, PCr levels and the
estimated H+ concentration, which was calculated from
a formula based on the muscle lactate content for dry
muscle (Mannion et al. 1993). The observed equilibrium
constant (Kobs) of 1.66 × 109 was used for creatine kinase
(Lawson & Veech, 1979). An estimation of AMPfree was
calculated from the measured ATP and estimated ADPfree,
using a Kobs of 1.05 for adenylate kinase (Lawson & Veech,
1979). Estimated ADPfree and AMPfree were expressed
as μmol per kilogram of dry muscle mass (μmol kg−1
dry muscle).
Immunoblotting. Frozen skeletal muscle was homo-
genised in ice cold lysis buffer on ice [10 μl mg–1
tissue; 50 mM Tris-HCl, pH 7.5, containing 1 mM
EDTA, 1 mM EGTA, 10% v/v glycerol, 1% v/v Triton
X-100, 50 mM NaF, 5 mM Na4P2O7, 1 mM dithiothreitol,
1 mM phenylmethylsulphonyl fluoride, 1 μl ml−1 trypsin
inhibitor and 5 μl ml−1 protease inhibitor cocktail
(P8340; Sigma, St Louis, MO, USA)], incubated on
ice for 20 min and centrifuged at 16 000 g for
20 min at 4°C. The protein concentration of samples
was determined using the bicinchoninic acid protein
assay (Pierce, Rockford, IL, USA) with BSA as the
standard. All primary antibodies were diluted to a final
concentration of 1:1000. Phosphospecific antibodies for
AMPK αThr172 and ACCβ Ser221 were purchased from
Upstate Biotechnology (Lake Placid, NY, USA; catalogue
no. 07–626 and 05–673, respectively). Polyclonal rabbit
antibody specific for total AMPK α protein was purchased
from Cell Signalling Technology (Beverley, MA, USA;
catalogue no. 2532). ACCβ was detected using IRDyeTM
800-labelled streptavidin (Rockland, Gilbertsville, PA,
USA; catalogue no. S000-45).
Skeletal muscle lysates (80 μg) were heated in SDS
sample buffer and subjected to SDS-PAGE. Binding
of purified proteins was detected by immunoblotting
following an overnight incubation with primary anti-
body. Membranes were incubated in Odyssey anti-rabbit
IRDyeTM 800- or anti-mouse IRDyeTM 700- labelled
secondary antibody (Rockland, Gilbertsville, PA, USA),
washed in PBS Tween 20 and were scanned for
infra-red fluorescence using an Odyssey Infrared Imaging
System (LI-COR Biosciences, Lincoln, NE, USA). When
both total protein and protein phosphorylation were
measured, membranes were probed first for total protein,
stripped of antibodies (2% SDS in 25 mM glycine, pH
2.0) and re-probed with the anti-phospho antibody.
Phosphorylation was expressed relative to the total protein
of the specific protein of interest.
AMPK activity. Skeletal muscle lysates (50 μg) were
combined with 15μl of protein A sepharose beads (Pierce),
bound to either AMPK α1 (raised to the non-conserved
region of the AMPK α1 isoform, amino acid sequence
373–390 of rat AMPK α1) or AMPK α2 (amino acid
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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Table 3. Measured and calculated muscle metabolites at rest (0 min), and after 30 min and 120 min of steady-state exercise at  65%
of V̇O2peak
Metabolite 0 min 30 min 120 min
Lactate Untrained § 4.6 ± 1.2 11.9 ± 3.4 27.5 ± 11.6∗
(mmol kg−1 dm) Trained §‡ 3.8 ± 2.1 8.9 ± 3.6 11.6 ± 4.9
PCr Untrained § 70.1 ± 15.5 46.1 ± 12.8 42.9 ± 11.5
(mmol kg−1 dm) Trained §‡ 78.9 ± 13.7 61.5 ± 17.0 56.6 ± 13.8
Cr Untrained § 38.5 ± 7.0 61.4 ± 18.3 69.7 ± 17.6
(mmol kg−1 dm) Trained §‡ 39.1 ± 6.1 55.1 ± 11.1 58.8 ± 15.9
PCr:(PCr + Cr) Untrained § 0.64 ± 0.07 0.44 ± 0.12 0.37 ± 0.13
Trained §‡ 0.66 ± 0.07 0.52 ± 0.12 0.50 ± 0.12
ATP Untrained 24.3 ± 2.2 24.1 ± 2.5 24.3 ± 3.5
(mmol kg−1 dm) Trained 24.4 ± 4.1 26.5 ± 6.2 24.1 ± 3.0
ADPfree Untrained § 131 ± 36 338 ± 239 409 ± 199
(μmol kg−1 dm) Trained § 109 ± 20 228 ± 66 248 ± 117
AMPfree Untrained § 0.8 ± 0.5 2.3 ± 0.8 13.5 ± 4.1∗
(μmol kg−1 dm) Trained §‡ 0.6 ± 0.3 2.4 ± 1.5 3.2 ± 2.6
AMPfree:ATP Untrained § 0.04 ± 0.02 0.08 ± 0.03 0.56 ± 0.17
Trained §‡ 0.03 ± 0.02 0.10 ± 0.07 0.13 ± 0.09
Values are the mean ± SD, n = 11 untrained and 7 exercise trained participants. PCr, creatine phosphate; Cr, creatine; ADPfree, free
adenosine diphosphate; AMPfree, free adenosine monophosphate, dm; dry muscle. ∗Significantly different to corresponding trained
value. §Main effect for time. ‡Main effect for untrained compared to trained (P < 0.05).
sequences 351–366 and 490–516 of rat AMPKα2) poly-
clonal antibodies (a gift from Professor Bruce Kemp,
St Vincent’s Institute of Medical Research, Fitzroy, VIC,
Australia) and incubated for 2 h at 4 °C. Immuno-
complexes were washed in lysis buffer containing 0.5 M
NaCl and resuspended in 25 μl of 0.05 M Tris buffer (pH
7.5). To commence the assay, 25 μl of reaction mixture
containing (final concentrations) 50 mM Tris/HCl, pH 7.5,
0.1 mM EGTA, 0.1% (by vol) 2-mercaptoethanol, 10 mM
magnesium acetate, 0.1 mM [32P]ATP (200 cpm/pmol;
PerkinElmer Life and Analytical Sciences, Boston, MA,
USA), 30 μM AMARA peptide (Upstate Biotechnology)
and 200 μM AMP was added to each sample at 30°C for
20 min with agitation. Then, 40 μl of each sample was
transferred onto P81 chromatography paper and washed
3 × 10 min in 75 mM H3PO4, once in 100% ethanol,
and air dried. P81 paper was then placed in organic
scintillation fluid (Opti-Fluor O; PerkinElmer) and radio-
activity was counted on a β counter (PerkinElmer).
AMARA peptide has the same AMPK phosphorylation
site as ACCβ; therefore, AMPK activities were calculated
as units of γ-[32P]-ATP incorporated into the AMARA
peptide [ACCα (73-87)A77] min−1 mg−1 total protein sub-
jected to immunoprecipitation.
Statistical analysis. Data are expressed as the mean ±
SD. Untrained and exercise trained group values were
compared using a two-factor (training × time) repeated
measures ANOVA and, if there was a significant inter-
action, the ANOVA was followed by a post hoc comparison
using a least significant difference test. P < 0.05 was
considered statistically significant.
Results
Subjects
There was no significant difference in age, weight, height
or body mass index between the untrained and exercise
trained groups (Table 1). However, as expected, V̇O2peak
was significantly higher in the endurance trained group
(P < 0.05) (Table 1) and the trained group cycled on
average at almost twice the workload of the untrained
group (P < 0.05) (Table 2). Importantly, the relative
exercise intensity was the same between groups, with no
significant difference for V̇O2 (as a percentage of V̇O2peak),
heart rate or rating of perceived exhaustion (Table 2).
Muscle metabolites
Measured muscle lactate and Cr and estimated ADPfree,
AMPfree and the AMPfree:ATP ratio all increased
progressively with exercise in both groups (Table 3). The
exercise induced increase in muscle lactate, Cr and AMPfree
was attenuated in the exercise trained compared to the
untrained group (P < 0.05) (Table 3). Skeletal muscle
AMPfree increased (P < 0.05) 17-fold in the untrained
group and significantly (P < 0.05) less (5-fold) in the end-
urance trained group following 120 min of exercise and
the muscle lactate concentration increased by 5.9-fold in
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
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the untrained and 3.1-fold in the well trained individuals
(P < 0.05) (Table 3). PCr and the PCr:(PCr+Cr) ratio
decreased progressively in both groups, and this decrease
was greater in untrained subjects (26% decrease in
untrained, 44% decrease in endurance trained groups,
P < 0.05) (Table 3). There was no difference in measured
ATP levels during exercise or between groups (P > 0.05)
(Table 3).
Resting muscle glycogen levels were 93% higher
(P < 0.05) in the exercise trained group, and remained
higher than the untrained values at 30 min (130%,
P < 0.05) and 120 min of exercise (440%, P < 0.05)
(Fig. 1). However, net glycogen utilization during exercise
was similar between the two groups.
Plasma glucose lactate, insulin, glycerol and NEFA
Plasma glucose concentration remained at a similar
level during exercise in untrained and endurance
trained subjects (P > 0.05) (Fig. 2A). Plasma lactate
was similar at rest in the two groups; however,
it was elevated by 110% in the untrained group
during exercise, which was significantly higher than the
trained group (P < 0.05) (Fig. 2B). Plasma insulin
decreased progressively throughout exercise in both
groups; however, fasting plasma insulin was 40% higher
in the untrained compared to the trained group at rest,
and remained 25% higher than the trained values
throughout 120 min of exercise (P < 0.05) (Fig. 2C).
Both plasma glycerol and NEFA increased progressively
throughout exercise in both groups; however, NEFA levels
were attenuated in the exercise trained group at 90 and
120 min (P < 0.05) (Fig. 3).
Figure 1. Muscle glycogen measurements in muscle samples
Muscle glycogen measured from muscle samples obtained before
exercise (rest), after 30 min and immediately following 120 min of
steady-state exercise at 65% V̇O2peak in untrained and exercise
trained participants. Data are the mean ± SD (n = 11 untrained, 7
trained. ∗Significantly different to corresponding trained value
(P < 0.05). §Main effect for time (P < 0.05).
AMPK signalling
Basal AMPK α1 activity was 90% higher (P < 0.05) in the
exercise trained group, whereas there was no difference in
basal AMPK α2 activity between the two groups (Fig. 4).
AMPK α1 activity increased by 220% and AMPK α2
activity increased by 370% during exercise in the untrained
Figure 2. Plasma glucose, lactate and insulin concentrations
Plasma glucose (A), plasma lactate (B) and plasma insulin (C)
concentrations at rest and during 120 min of steady-state exercise at
65% V̇O2peak in untrained and exercise trained participants. Data
are the mean ± SD, n = 11 untrained, 7 trained. ∗Significantly
different from corresponding trained value (P < 0.05).
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group at 120 min (P < 0.05). However, neither AMPK α1,
nor AMPKα2 activity increased during exercise in the end-
urance trained group (P > 0.05) (Fig. 4). AMPK αThr172
(115%, P < 0.05) phosphorylation and ACCβ Ser222
phosphorylation (100%, P < 0.05) increased with exercise
in the untrained group after 120 min of exercise (Fig. 5).
However, there was no significant increase in AMPK
αThr172 phosphorylation or ACCβSer222 phosphorylation
during exercise in the trained group (P > 0.05) (Fig. 5).
Discussion
The results of the present study show that AMPK activity
is not increased during prolonged steady-state, moderate
intensity exercise in endurance trained individuals.
Indeed, AMPK α1 and α2 activity was significantly
elevated following 120 min of exercise in the untrained
group (220% and 370%, respectively), whereas no increase
in AMPK activity was observed during exercise in the
trained participants (Fig. 4). Given that there is a sub-
stantial amount of glucose and fat oxidised during 120 min
Figure 3. Plasma glycerol and nonesterified fatty acid
concentrations
Plasma glycerol (A) and plasma nonesterified fatty acid (NEFA) (B)
concentrations at rest and during 120 min of steady-state exercise at
65% V̇O2peak in untrained and exercise trained participants. Data
are the mean ± SD, n = 11 untrained, 7 trained.
of exercise at 65% V̇O2peak in endurance trained individuals
(Romijn et al. 1993; van Loon et al. 2001), these results
indicate that AMPK activation is not important for
exercise metabolism under these circumstances.
Almost every study investigating AMPK states in their
Introduction that AMPK regulates glucose uptake and
fat oxidation during exercise, despite much evidence to
the contrary. Indeed, our current findings are consistent
with our previous results indicating that, after 10 days of
exercise training, there was no increase from rest in skeletal
muscle AMPK activity, AMPK αThr172 phosphorylation
or ACCβ phosphorylation during 120 min of exercise at
65% of pre-training V̇O2peak despite substantial glucose
disposal and higher fat oxidation during exercise after
(compared to before) exercise training (McConell et al.
2005). Other studies similarly report in humans that
skeletal muscle AMPK activation is barely increased during
exercise at 65% V̇O2peak after 12 weeks of exercise training
(Mortensen et al. 2013). Although not universally the
case (Mu et al. 2001; Sakamoto et al. 2005; Lee-Young
et al. 2009), many rodent studies have found that there
are normal increases in glucose uptake and fat oxidation
during contraction or during exercise in AMPK kinase
dead or AMPK knockout mice (Jorgensen et al. 2004;
Figure 4. Skeletal muscle AMPK α1 and α2 activity
AMPK α1 (A) and α2 activity (B). Muscle samples were obtained
before exercise (rest), after 30 min and immediately following
120 min of steady-state exercise at 65% V̇O2peak in untrained and
exercise trained participants. Data are the mean ± SD, n = 11
untrained, 7 trained. ∗Significantly different from corresponding
trained value (P < 0.05). §Main effect for time (P < 0.05).
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Fujii et al. 2005; Merry et al. 2010b; Jeppesen et al. 2011;
Jeppesen et al. 2013; Kjobsted et al. 2017).
Unlike the present study, it was reported previously
that skeletal muscle AMPK activity increases similarly in
untrained and well trained people cycling for 20 min at
80% V̇O2peak (Nielsen et al. 2003). In addition, Clark et al.
(2004) found AMPK activity increased similarly during
repeated bouts of exercise at 85% V̇O2peak after exercise
training despite evidence of lower energy deficit after
the exercise training. In the present study, exercise was
performed at 65% of V̇O2peak (untrained 66%; trained
65%) (Table 2); some may argue that this workload is quite
easy for trained individuals and so no increase in AMPK
activation would be expected. However, because there
are 2–3-fold increases from rest in whole-body glucose
uptake and fat oxidation during moderate intensity
exercise at 65% V̇O2peak in endurance trained individuals
(Romijn et al. 1993; van Loon et al. 2001), factors that
are important to mediating exercise metabolism should
be enhanced at these workloads. Therefore, activation
of skeletal muscle AMPK is probably not necessary for
increases in glucose uptake and fat oxidation during
moderate intensity exercise in humans. These findings
are also supported by other human studies that found
dissociations between AMPK activation and glucose
uptake and fat oxidation during prolonged exercise at
40–45% V̇O2max (Chen et al. 2000; Wojtaszewski et al.
2002).
AMPK activity is increased by upstream kinase
phosphorylation and allosterically by increases in AMP
(Hardie, 2004; Sakamoto et al. 2005). In addition, ADP
increases AMPK activity by preventing dephosphorylation
of AMPK (Xiao et al. 2011). Exercise increases skeletal
muscle free ADP and AMP (McConell et al. 1999) and
exercise training attenuates the normal increases in ADP
and AMP during exercise compared to untrained muscle
(Gollnick & Hermansen, 1973). Indeed, in the present
study, we report an attenuated increase in calculated AMP
and ADP during exercise in the well trained compared
to the untrained participants (Table 3) and thus would
Figure 5. Skeletal muscle AMPK αThr172
and ACC-βSer221 phosphorylation
Representative immunoblot of AMPK
αThr172 phosphorylation (A) measured
using a phosphospecific antibody for AMPK
αThr172, normalized to total AMPK α
protein; and ACC-βSer221 phosphorylation
(B) measured using a phosphospecific
antibody specific to ACC-βSer221,
normalized to total ACC-β. Muscle samples
were obtained before exercise (rest), after
30 min and immediately following 120 min
of steady-state exercise at 65% V̇O2peak in
untrained and exercise trained participants.
Samples of pAMPK or AMPK for each
participant were run on the same western
blot. The representative western blots for
pAMPK or AMPK shown are from the same
membrane but are rearranged for clarity.
Data are the mean ± SD, n = 11 untrained,
7 trained. ∗Significantly different from
corresponding trained value (P < 0.05).
§Main effect for time (P < 0.05).
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have expected a similar attenuated response in AMPK
activity. In the present study, despite the five-fold increase
in AMPfree during exercise in the trained individuals
AMPK activity was not increased from rest. Future studies
should investigate whether there is a reduction in AMPK
sensitivity to AMP and ADP during moderate intensity
exercise after exercise training. This could be carried out
in highly trained endurance subjects by using exercise
intensity to titrate the free AMP levels to compare the
threshold for AMPK activation during exercise in end-
urance trained vs. untrained individuals.
It is possible that AMPK activation during exercise in
the trained individuals was restrained by the higher muscle
glycogen since muscle glycogen content has also been
implicated as a potential regulator of AMPK activation
during exercise. Indeed, the β subunit contains a glycogen
binding domain that associates with glycogen in cell free
assays (Hudson et al. 2003; Polekhina et al. 2003). High
muscle glycogen has been shown to inhibit contraction
induced AMPK activation without influencing glucose
uptake in rats (Derave et al. 2000). However, there
is evidence to suggest that AMPK does not associate
with glycogen in vivo (Viollet et al. 2003; Parker et al.
2007). Indeed our laboratory has shown that muscle
glycogen is not responsible for abolished AMPK activity
during exercise in humans. Following short-term exercise
training, there is no increase in AMPK activity during
exercise commenced with normal or high glycogen levels
(McConell et al. 2005). In the present study, muscle
glycogen content was 93% higher in the trained sub-
jects at rest, and remained higher than untrained values
throughout the exercise trial (Fig. 1). However, given
the findings of our short-term exercise training study
(McConell et al. 2005), as well as other evidence of a lack of
importance of AMPK for in vivo muscle glycogen content
(Viollet et al. 2003), the higher muscle glycogen content
in the endurance trained individuals was probably not
responsible for the abolished increase in AMPK activity
during exercise.
It is not clear why activation of AMPK αThr172
phosphorylation and AMPK activity did not occur during
exercise in the exercise trained individuals; however, there
is some evidence to suggest that training is associated
with changes in the regulation of upstream AMPKK(s).
For example, endurance training in rats decreases basal
LKB1 activity (Hurst et al. 2005) and decreases AMPK
activity during exercise (Durante et al. 2002). It is also not
known what effect exercise training has on PP2C activity,
and it may be that increases in PP2C activity following
training are preventing AMPK αThr172 phosphorylation
and increases in AMPK activity during exercise. PP2C
has previously been shown to inhibit the activity of both
AMPK α1 and α2 isoforms (Davies et al. 1995); however,
further studies are required to determine whether changes
in PP2C activity occur following exercise training.
In summary, the present study found that, unlike
untrained individuals, endurance trained men have
no increase in skeletal muscle AMPK activity, AMPK
phosphorylation or ACC phosphorylation during 120 min
of cycling exercise at 65% V̇O2peak. This finding is
consistent with results following short-term exercise
training where no increase in AMPK activation during
moderate intensity exercise is also observed (McConell
et al. 2005). Given that skeletal muscle AMPK is not
activated but fat oxidation and glucose uptake are sub-
stantial during moderate intensity exercise after exercise
training, these results indicate that AMPK does not
regulate metabolism under these circumstances.
References
Abbott MJ, Bogachus LD & Turcotte LP (2011). AMPKalpha2
deficiency uncovers time dependency in the regulation of
contraction-induced palmitate and glucose uptake in mouse
muscle. J Appl Physiol (1985) 111, 125–134.
Baldwin J, Snow RJ, Carey MF & Febbraio MA (1999). Muscle
IMP accumulation during fatiguing submaximal exercise in
endurance trained and untrained men. Am J Physiol 277,
R295–R300.
Balon TW & Nadler JL (1997). Evidence that nitric oxide
increases glucose transport in skeletal muscle. J Appl Physiol
82, 359–363.
Bradley SJ, Kingwell BA & McConell GK (1999). Nitric oxide
synthase inhibition reduces leg glucose uptake but not blood
flow during dynamic exercise in humans [published erratum
appears in Diabetes 1999 Dec;48(12):2480]. Diabetes 48,
1815–1821.
Chen ZP, Stephens TJ, Murthy S, Canny BJ, Hargreaves M,
Witters LA, Kemp BE & McConell GK (2003). Effect of
exercise intensity on skeletal muscle AMPK signaling in
humans. Diabetes 52, 2205–2212.
Chen ZP, McConell GK, Michell BJ, Snow RJ, Canny BJ &
Kemp BE (2000). AMPK signaling in contracting human
skeletal muscle: acetyl-CoA carboxylase and NO synthase
phosphorylation. Am J Physiol Endocrinol Metab 279,
E1202–E1206.
Chernick S (1969). Determination of Glycerol in Acyl Glycerols.
Academic Press, New York, NY.
Clark SA, Chen ZP, Murphy KT, Aughey RJ, McKenna MJ,
Kemp BE & Hawley JA (2004). Intensified exercise training
does not alter AMPK signaling in human skeletal muscle.
Am J Physiol Endocrinol Metab 286, E737–E743.
Davies SP, Helps NR, Cohen PT & Hardie DG (1995). 5’-AMP
inhibits dephosphorylation, as well as promoting
phosphorylation, of the AMP-activated protein kinase.
Studies using bacterially expressed human protein
phosphatase-2C alpha and native bovine protein
phosphatase-2AC. FEBS Lett 377, 421–425.
Derave W, Ai H, Ihlemann J, Witters LA, Kristiansen S, Richter
EA & Ploug T (2000). Dissociation of AMP-activated protein
kinase activation and glucose transport in contracting
slow-twitch muscle. Diabetes 49, 1281–1287.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
3868 G. K. McConell and others J Physiol 598.18
Durante PE, Mustard KJ, Park SH, Winder WW & Hardie DG
(2002). Effects of endurance training on activity and
expression of AMP-activated protein kinase isoforms in rat
muscles. Am J Physiol Endocrinol Metab 283, E178–E186.
Fujii N, Hayashi T, Hirshman MF, Smith JT, Habinowski SA,
Kaijser L, Mu J, Ljungqvist O, Birnbaum MJ, Witters LA,
Thorell A & Goodyear LJ (2000). Exercise induces
isoform-specific increase in 5’AMP-activated protein kinase
activity in human skeletal muscle. Biochem Biophys Res
Commun 273, 1150–1155.
Fujii N, Hirshman MF, Kane EM, Ho RC, Peter LE, Seifert MM
& Goodyear LJ (2005). AMP-activated protein kinase alpha2
activity is not essential for contraction- and
hyperosmolarity-induced glucose transport in skeletal
muscle. J Biol Chem 280, 39033–39041.
Gollnick PD & Hermansen L (1973). Biochemical adaptations
to exercise: anaerobic metabolism. Exerc Sport Sci Rev 1,
1–43.
Hardie DG (2004). The AMP-activated protein kinase
pathway–new players upstream and downstream. J Cell Sci
117, 5479–5487.
Harris RC, Hultman E & Nordesjo LO (1974). Glycogen,
glycolytic intermediates and high-energy phosphates
determined in biopsy samples of musculus quadriceps
femoris of man at rest. Methods and variance of values.
Scand J Clin Lab Invest 33, 109–120.
Hayashi T, Hirshman MF, Fujii N, Habinowski SA, Witters LA
& Goodyear LJ (2000). Metabolic stress and altered glucose
transport: activation of AMP-activated protein kinase as a
unifying coupling mechanism. Diabetes 49, 527–531.
Hayashi T, Hirshman MF, Kurth EJ, Winder WW & Goodyear
LJ (1998). Evidence for 5’ AMP-activated protein kinase
mediation of the effect of muscle contraction on glucose
transport. Diabetes 47, 1369–1373.
Hudson ER, Pan DA, James J, Lucocq JM, Hawley SA, Green
KA, Baba O, Terashima T & Hardie DG (2003). A novel
domain in AMP-activated protein kinase causes glycogen
storage bodies similar to those seen in hereditary cardiac
arrhythmias. Curr Biol 13, 861–866.
Hurst D, Taylor EB, Cline TD, Greenwood LJ, Compton CL,
Lamb JD & Winder WW (2005). AMP-activated protein
kinase kinase activity and phosphorylation of
AMP-activated protein kinase in contracting muscle of
sedentary and endurance-trained rats. Am J Physiol
Endocrinol Metab 289, E710–E715.
Inyard AC, Clerk LH, Vincent MA & Barrett EJ (2007).
Contraction stimulates nitric oxide independent
microvascular recruitment and increases muscle insulin
uptake. Diabetes 56, 2194–2200.
Jensen TE, Rose AJ, Jorgensen SB, Brandt N, Schjerling P,
Wojtaszewski JF & Richter EA (2007). Possible
CaMKK-dependent regulation of AMPK phosphorylation
and glucose uptake at the onset of mild tetanic skeletal
muscle contraction. Am J Physiol Endocrinol Metab 292,
E1308–E1317.
Jeppesen J, Albers PH, Rose AJ, Birk JB, Schjerling P, Dzamko
N, Steinberg GR & Kiens B (2011). Contraction-induced
skeletal muscle FAT/CD36 trafficking and FA uptake is
AMPK independent. J Lipid Res 52, 699–711.
Jeppesen J, Maarbjerg SJ, Jordy AB, Fritzen AM, Pehmoller C,
Sylow L, Serup AK, Jessen N, Thorsen K, Prats C, Qvortrup
K, Dyck JR, Hunter RW, Sakamoto K, Thomson DM,
Schjerling P, Wojtaszewski JF, Richter EA & Kiens B (2013).
LKB1 regulates lipid oxidation during exercise
independently of AMPK. Diabetes 62, 1490–1499.
Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB,
Schjerling P, Vaulont S, Richter EA & Wojtaszewski JF
(2004). Knockout of the alpha2 but
not alpha1 5’-AMP-activated protein kinase isoform abolishes
5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut
not contraction-induced glucose uptake in skeletal muscle. J
Biol Chem 279, 1070–1079.
Kjobsted R, Munk-Hansen N, Birk JB, Foretz M, Viollet B,
Bjornholm M, Zierath JR, Treebak JT & Wojtaszewski JF
(2017). Enhanced Muscle Insulin Sensitivity After
Contraction/Exercise Is Mediated by AMPK. Diabetes 66,
598–612.
Lawson JW & Veech RL (1979). Effects of pH and free Mg2+ on
the Keq of the creatine kinase reaction and other phosphate
hydrolyses and phosphate transfer reactions. J Biol Chem
254, 6528–6537.
Lee-Young RS, Griffee SR, Lynes SE, Bracy DP, Ayala JE,
McGuinness OP & Wasserman DH (2009). Skeletal muscle
AMP-activated protein kinase is essential for the metabolic
response to exercise in vivo. J Biol Chem 284,
23925–23934.
Linden KC, Wadley GD, Garnham AP & McConell GK (2011).
Effect of l-arginine infusion on glucose disposal during
exercise in humans. Med Sci Sports Exerc 43, 1626–1634.
Lowry OH (1972). Academic Press, New York.
Mannion AF, Jakeman PM & Willan PL (1993). Determination
of human skeletal muscle buffer value by homogenate
technique: methods of measurement. J Appl Physiol (1985)
75, 1412–1418.
McConell G, Snow RJ, Proietto J & Hargreaves M (1999).
Muscle metabolism during prolonged exercise in humans:
influence of carbohydrate availability. J Appl Physiol 87,
1083–1086.
McConell GK, Lee-Young RS, Chen ZP, Stepto NK, Huynh
NN, Stephens TJ, Canny BJ & Kemp BE (2005). Short-term
exercise training in humans reduces AMPK signalling during
prolonged exercise independent of muscle glycogen. J Physiol
568, 665–676.
McGee SL, Howlett KF, Starkie RL, Cameron-Smith D, Kemp
BE & Hargreaves M (2003). Exercise increases nuclear AMPK
alpha2 in human skeletal muscle. Diabetes 52, 926–928.
Merrill GF, Kurth EJ, Hardie DG & Winder WW (1997). AICA
riboside increases AMP-activated protein kinase, fatty acid
oxidation, and glucose uptake in rat muscle. Am J Physiol
273, E1107–E1112.
Merry TL, Lynch GS & McConell GK (2010a). Downstream
mechanisms of nitric oxide-mediated skeletal muscle glucose
uptake during contraction. Am J Physiol Regul Integr Comp
Physiol 299, R1656–R1665.
Merry TL, Steinberg GR, Lynch GS & McConell GK (2010b).
Skeletal muscle glucose uptake during contraction is
regulated by nitric oxide and ROS independently of AMPK.
Am J Physiol Endocrinol Metab 298, E577–E585.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
J Physiol 598.18 AMPK during submaximal exercise in endurance trained men 3869
Mortensen B, Hingst JR, Frederiksen N, Hansen RW,
Christiansen CS, Iversen N, Friedrichsen M, Birk JB,
Pilegaard H, Hellsten Y, Vaag A & Wojtaszewski JF (2013).
Effect of birth weight and 12 weeks of exercise training on
exercise-induced AMPK signaling in human skeletal muscle.
Am J Physiol Endocrinol Metab 304, E1379–E1390.
Mu J, Brozinick JT, Jr., Valladares O, Bucan M & Birnbaum MJ
(2001). A role for AMP-activated protein kinase in
contraction- and hypoxia- regulated glucose transport in
skeletal muscle. Mol Cell 7, 1085–1094.
Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist
O, Thorell A & Goodyear LJ (2001). AMP-activated protein
kinase (AMPK) is activated in muscle of subjects with type 2
diabetes during exercise. Diabetes 50, 921–927.
Nielsen JN, Mustard KJ, Graham DA, Yu H, MacDonald CS,
Pilegaard H, Goodyear LJ, Hardie DG, Richter EA &
Wojtaszewski JF (2003). 5’-AMP-activated protein kinase
activity and subunit expression in exercise-trained human
skeletal muscle. J Appl Physiol (1985) 94, 631–641.
Parker GJ, Koay A, Gilbert-Wilson R, Waddington LJ &
Stapleton D (2007). AMP-activated protein kinase does not
associate with glycogen alpha-particles from rat liver.
Biochem Biophys Res Commun 362, 811–815.
Passonneau JV & Lauderdale VR (1974). A comparison of three
methods of glycogen measurement in tissues. Anal Biochem
60, 405–412.
Polekhina G, Gupta A, Michell BJ, van Denderen B, Murthy S,
Feil SC, Jennings IG, Campbell DJ, Witters LA, Parker MW,
Kemp BE & Stapleton D (2003). AMPK beta subunit targets
metabolic stress sensing to glycogen. Curr Biol 13, 867–871.
Reid MB & Durham WJ (2002). Generation of reactive oxygen
and nitrogen species in contracting skeletal muscle: potential
impact on aging. Ann N Y Acad Sci 959, 108–116.
Richter EA & Hargreaves M (2013). Exercise, GLUT4, and
skeletal muscle glucose uptake. Physiol Rev 93, 993–1017.
Roberts CK, Barnard RJ, Jasman A & Balon TW (1999). Acute
exercise increases nitric oxide synthase activity in skeletal
muscle. Am J Physiol 277, E390–E394.
Roberts CK, Barnard RJ, Scheck SH & Balon TW (1997).
Exercise-stimulated glucose transport in skeletal muscle is
nitric oxide dependent. Am J Physiol Endocrinol Metab 273,
E220–E225.
Romijn JA, Coyle EF, Sidossis LS, Gastaldelli A, Horowitz JF,
Endert E & Wolfe RR (1993). Regulation of endogenous fat
and carbohydrate metabolism in relation to exercise
intensity and duration. Am J Physiol Endocrinol Metab 265,
E380–E391.
Ross RM, Wadley GD, Clark MG, Rattigan S & McConell GK
(2007). Local NOS inhibition reduces skeletal muscle
glucose uptake but not capillary blood flow during in situ
muscle contraction in rats. Diabetes 56, 2885–2892.
Sakamoto K, McCarthy A, Smith D, Green KA, Grahame
Hardie D, Ashworth A & Alessi DR (2005). Deficiency of
LKB1 in skeletal muscle prevents AMPK activation and
glucose uptake during contraction. EMBO J 24, 1810–1820.
Sandstrom ME, Zhang SJ, Bruton J, Silva JP, Reid MB,
Westerblad H & Katz A (2006). Role of reactive oxygen
species in contraction-mediated glucose transport in mouse
skeletal muscle. J Physiol 575, 251–262.
Sylow L, Jensen TE, Kleinert M, Mouatt JR, Maarbjerg SJ,
Jeppesen J, Prats C, Chiu TT, Boguslavsky S, Klip A,
Schjerling P & Richter EA (2013). Rac1 is a novel regulator
of contraction-stimulated glucose uptake in skeletal muscle.
Diabetes 62, 1139–1151.
Sylow L, Moller LL, Kleinert M, Richter EA & Jensen TE
(2015). Stretch-stimulated glucose transport in skeletal
muscle is regulated by Rac1. J Physiol 593, 645–656.
Toyoda T, Hayashi T, Miyamoto L, Yonemitsu S, Nakano M,
Tanaka S, Ebihara K, Masuzaki H, Hosoda K, Inoue G, Otaka
A, Sato K, Fushiki T & Nakao K (2004). Possible involvement
of the alpha1 isoform of 5’AMP-activated protein kinase in
oxidative stress-stimulated glucose transport in skeletal
muscle. Am J Physiol Endocrinol Metab 287, E166–E173.
van Loon LJ, Greenhaff PL, Constantin-Teodosiu D, Saris WH
& Wagenmakers AJ (2001). The effects of increasing exercise
intensity on muscle fuel utilisation in humans. J Physiol 536,
295–304.
Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, Mu J,
Wojtaszewski JF, Schuit FC, Birnbaum M, Richter E,
Burcelin R & Vaulont S (2003). Physiological role of
AMP-activated protein kinase (AMPK): insights from
knockout mouse models. Biochem Soc Trans 31,
216–219.
Winder WW & Hardie DG (1996). Inactivation of acetyl-CoA
carboxylase and activation of AMP-activated protein kinase
in muscle during exercise. Am J Physiol 270,
E299–E304.
Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M &
Holloszy JO (2000). Activation of AMP-activated protein
kinase increases mitochondrial enzymes in skeletal muscle. J
Appl Physiol 88, 2219–2226.
Witczak CA, Jessen N, Warro DM, Toyoda T, Fujii N, Anderson
ME, Hirshman MF & Goodyear LJ (2010). CaMKII regulates
contraction- but not insulin-induced glucose uptake in
mouse skeletal muscle. Am J Physiol Endocrinol Metab 298,
E1150–E1160.
Wojtaszewski JF, Mourtzakis M, Hillig T, Saltin B &
Pilegaard H (2002). Dissociation of AMPK activity and
ACCbeta phosphorylation in human muscle during
prolonged exercise. Biochem Biophys Res Commun 298,
309–316.
Wojtaszewski JF, Nielsen P, Hansen BF, Richter EA & Kiens B
(2000). Isoform-specific and exercise intensity-dependent
activation of 5’-AMP-activated protein kinase in human
skeletal muscle. J Physiol 528, 221–226.
Wright DC, Geiger PC, Holloszy JO & Han DH (2005).
Contraction- and hypoxia-stimulated glucose transport is
mediated by a Ca2+-dependent mechanism in slow-twitch
rat soleus muscle. Am J Physiol Endocrinol Metab 288,
E1062–E1066.
Wright DC, Hucker KA, Holloszy JO & Han DH (2004). Ca2+
and AMPK both mediate stimulation of glucose transport by
muscle contractions. Diabetes 53, 330–335.
Xiao B, Sanders MJ, Underwood E, Heath R, Mayer FV,
Carmena D, Jing C, Walker PA, Eccleston JF, Haire LF, Saiu
P, Howell SA, Aasland R, Martin SR, Carling D & Gamblin
SJ (2011). Structure of mammalian AMPK and its regulation
by ADP. Nature 472, 230–233.
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
3870 G. K. McConell and others J Physiol 598.18
Additional information
Data availability statement
The data that support the findings of this study are available
from the corresponding author upon reasonable request.
Competing interests
The authors declare that they have no competing interests.
Funding
This work was supported by a grant from the National Health
and Medical Research Council (NHMRC) of Australia (GKM:
237002).
Author contributions
GKM, KCL and GDW designed the study. GKM, KCL conducted
the exercise tests. GKM, KCL, GDW and KLP conducted the
experiments. KCL and GDW conducted the analysis. GKM and
KCL drafted the manuscript. All authors revised the manuscript
critically.
Acknowledgements
We thank the participants for taking part in this study and
acknowledge the technical assistance of Mrs Judith Gooley,
Assistant Professor Sean McGee, Dr Rob Lee-Young and
Professor Benedict Canny. This work was supported by a
grant from the National Health and Medical Research Council
(NHMRC) of Australia (GKM: 237002). GKM was a Danish
Diabetes Academy Visiting Professor during the writing of this
manuscript (supported by a research grant from the Danish
Diabetes Academy, which is funded by the Novo Nordisk
Foundation Grant NNF17SA0031406).
Keywords
AMPK activity, endurance, exercise, metabolism, trained,
training, signalling
Supporting information
Additional supporting information may be found online in the
Supporting Information section at the end of the article.
Statistical Summary Document
C© 2020 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society.
